公司概覽
業務類別 --
業務概覽 Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
公司地址 Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, GBR, WD18 8YE
電話號碼 +44 1923477100
傳真號碼 --
公司網頁 https://www.smith-nephew.com
員工數量 17349
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. John Terence Rogers Executive Director,Chief Financial Officer 美元 695.00K 05/03/2026
Ms. Helen Barraclough Company Secretary & General Council -- 05/03/2026
Mr. Deepak S. Nath Executive Director,Chief Executive Officer 美元 1.56M 05/03/2026
 
董事會成員
董事會 職務 更新日期
Mr. Jeremy Kim Maiden Non-Executive Director 05/03/2026
Ms. Joanna Christine Hallas Non-Executive Director 05/03/2026
Mr. John Terence Rogers Executive Director,Chief Financial Officer 05/03/2026
Mr. Deepak S. Nath Executive Director,Chief Executive Officer 05/03/2026
Dr. John Ma Non-Executive Director 05/03/2026
Dr. Garheng Kong, M.D.,PhD Non-Executive Director 05/03/2026
Mr. Simon Jonathan Lowth Non-Executive Director 05/03/2026
Dr. Katarzyna Mazur-Hofsaess, PhD Non-Executive Director 05/03/2026
Ms. Therese Esperdy Non-Executive Director,Senior Independent Director 05/03/2026
Ms. Angie Risley Non-Executive Director,Senior Independent non-executive director 05/03/2026
Mr. Marc E. Owen Non-Executive Director 05/03/2026
Mr. Rupert C Soames OBE Non-Executive Director,Chairman 05/03/2026
Mr. David P King Non-Executive Director 05/03/2026
Ms. Sybella Jane Stanley Non-Executive Director 05/03/2026
 
所屬ETF (更新日期: 07/03/2026 02:08)
代號 名稱 佔比% 持有日期
BBINJPMorgan BetaBuilders Intl Eq ETF0.03%27/02/2026
FLGBFranklin FTSE United Kingdom ETF0.03%28/02/2026
IVLUiShares Edge MSCI Intl Value Factor ETF0.03%28/02/2026
DWXState Street® SPDR® S&P® Intl Div ETF0.03%27/02/2026
ACWXiShares MSCI ACWI ex US ETF0.02%28/02/2026
VSGXVanguard ESG International Stock ETF0.02%31/01/2026
GSIEGoldman Sachs ActiveBeta® Intl Eq ETF0.02%27/02/2026
DEXDelaware Enhanced Gbl Div & Income0.02%31/01/2023
IEViShares Europe ETF0.01%28/02/2026
CWIState Street® SPDR® MSCI ACWI ex-US ETF0.01%27/02/2026
UIVMVictoryShares International Val MomtETF0.01%27/02/2026
PXFInvesco RAFI Developed Markets ex-US ETF0.01%24/02/2026
JPINJPMorgan Diversified Return Intl Eq ETF0.01%27/02/2026
GKATScharf Global Opportunity ETF0.01%31/10/2025
SAGPStrategas Global Policy Opp ETF0.01%27/02/2026
BRIEMFS Blended Research Intl Eq ETF0.01%27/02/2026
IGDVoya Global Equity Dividend&Premium Opp0.01%31/01/2026
DFAXDimensional World ex US Core Eq 2 ETF0.01%27/02/2026
DFICDimensional International Core Eq 2 ETF0.01%27/02/2026
DIVIFranklin Intl Core Div Tlt Idx ETF0.01%28/02/2026
  1   2    3    4    5  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.